[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
January 9, 2006

The PSA Conundrum

Arch Intern Med. 2006;166(1):7-8. doi:10.1001/archinte.166.1.7

In the United States at least, physicians are generally convinced that when the evidence is in, screening for prostate cancer with the prostate-specific antigen (PSA) test will be shown to do more good than harm. Support for that opinion can be found in physicians’ personal decisions about PSA testing: as of 2000, 78% of male primary care physicians and 95% of male urologists 50 years and older in a national sample reported having had a PSA test.1